Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase-Reference-Cited by-同舟云学术

Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase

Published:2024-07-15 Issue: Volume: Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Knörnschild Franz L.¹^ORCID,Liebig Sven²^ORCID,Kießling Peggy³,Prpic Monika¹^ORCID,Kim Tehyung²,Keller Ulrich²⁴⁵^ORCID,Kappert Kai¹³^ORCID,Schwartz Stefan²⁴^ORCID,Jahic Amir¹³^ORCID

Affiliation:

1. Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry , Charité – Universitätsmedizin Berlin , Berlin , Germany

2. Department of Hematology, Oncology and Cancer Immunology , Charité – Universitätsmedizin Berlin , Berlin , Germany

3. Labor Berlin – Charité Vivantes GmbH , Berlin , Germany

4. German Cancer Consortium (DKTK) , Partner Site Berlin, A Partnership Between DKFZ and Charité – Universitätsmedizin Berlin , Berlin , Germany

5. Max-Delbrück-Center , Berlin , Germany

Funder

SERB SAS

Protherics Medicines Development Ltd.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2024-0523/pdf

Reference9 articles.

1. Widemann, BC, Adamson, PC. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006;11:694–703. https://doi.org/10.1634/theoncologist.11-6-694.

2. Garneau, AP, Riopel, J, Isenring, P. Acute methotrexate-induced crystal nephropathy. N Engl J Med 2015;373:2691–3. https://doi.org/10.1056/nejmc1507547.

3. Sherwood, RF, Melton, RG, Alwan, SM, Hughes, P. Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method. Eur J Biochem 1985;148:447–53. https://doi.org/10.1111/j.1432-1033.1985.tb08860.x.

4. Schwartz, S, Borner, K, Muller, K, Martus, P, Fischer, L, Korfel, A, et al.. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy. Oncologist 2007;12:1299–308. https://doi.org/10.1634/theoncologist.12-11-1299.

5. Widemann, BC, Balis, FM, Kim, A, Boron, M, Jayaprakash, N, Shalabi, A, et al.. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome. J Clin Oncol 2010;28:3979–86. https://doi.org/10.1200/jco.2009.25.4540.